Home | FUJIFILM Toyama Chemical Co., Ltd.

This website uses cookies. By using the site you are agreeing to our Privacy Policy.

Top of the page.

Skip the menu to main contents.: Move to main menu.; Skip to main contents.

Help Menu starts here.

Skip the Help menu to Search Within Site Feature.

FUJIFILM

Search Within Site Feature starts here.

Skip the Search Within Site Feature to main menu.

Help Menu starts here.

Skip the Help menu to main menu.

Main menu starts here.

Skip the main menu to current location in your website.

Start main contents.

[Photo]

Pickup

Information of Avigan Tablet in relation to Covid-19Learn more

Products

Corporate Profile

Development Information

Pipeline

What's New

Oct. 22, 2020: Fujifilm Partners with Chinese Pharmaceutical Company Carelink in Deploying Anti-influenza Drug Avigan^® Tablets in China (FUJIFILM Corporation)

Oct. 16, 2020: Fujifilm Filed an Application for Partial Changes to the Manufacturing and Marketing Approval Matters of Anti-Influenza Drug Avigan^® Tablet in Japan to Include Additional Indication for COVID-19 (FUJIFILM Corporation)

Sep. 23, 2020: Anti-influenza drug Avigan^® Tablet
Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 patients (FUJIFILM Corporation)

Aug. 31, 2020: To realize a new therapeutic option for neuroendocrine tumors
Domestic marketing approval application filed for new radiopharmaceutical F-1515

Jul. 1, 2020: Fujifilm partners with Dr. Reddy’s and Global Response Aid for deployment of a COVID-19 treatment drug outside of Japan
Licensing agreement was signed on the development, manufacture and sales of anti-influenza virus drug Avigan^® Tablets.
(FUJIFILM Corporation)

More

Related Information

FUJIFILM Corporation

Operating company that leads the Fujifilm Group's imaging and information solutions.

Footer starts here.

©FUJIFILM Toyama Chemical Co., Ltd.

Pages ends here.

Move to top of the page.